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Mammary gland development and differentiation is regulated by a number of growth factors and hormones. Milk protein gene expression
represents a hallmark of functional mammary epithelial differentiation and is coordinated by the lactogenic hormone prolactin and
glucocorticoids. To date, few ‘early-response’ genes transcriptionally activated by lactogenic hormones have been described. We have used
representational difference analysis (RDA) to search for lactogenic-responsive genes in SCp2 mouse mammary epithelial cells. One of the
cDNAs identified encoded the DNA-binding protein Taxreb107, originally identified as a HTLV-I Tax responsive element binding protein.
Increased Taxreb107 expression was confirmed following prolactin and dexamethasone-induced differentiation of SCp2 and HC11 mammary
epithelial cells. Taxreb107 RNA levels were developmentally regulated in the mouse mammary gland, where levels increased substantially
during mid- and late pregnancy and persisted during lactation. Overexpression of an antisense Taxreb107 cDNA construct or antisense
oligonucleotide in HC11 mammary epithelial cells attenuated milk protein gene expression following prolactin and dexamethasone treatment.
These findings indicate a role for Taxreb107 as a lactogenic hormone-responsive gene during differentiation of the mammary gland.
D 2003 Elsevier B.V. All rights reserved.Keywords: Glucocorticoid; Mammary gland differentiation; Lactogenic; Prolactin; Representational difference analysis; Ribosomal L6 protein; Subtractive
hybridisation; Taxreb1071. Introduction
Mammary gland development can be divided into devel-
opmental stages comprising ductal growth and branching
morphogenesis during puberty, alveolar budding and lobule
formation during pregnancy, terminal differentiation during
lactation that follows parturition, and postlactational invo-
lution. This process is tightly regulated by a number of
systemic hormones including prolactin, which directs ex-
pansion and differentiation of the mammary lobuloalveolar
epithelium [1–3], and glucocorticoids, which act in synergy
with prolactin and insulin to induce terminal differentiation
and milk production [4,5].
The roles of prolactin and glucocorticoid signaling in
mammary gland proliferation and differentiation have been0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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Switzerland.explored using knockout mice. Targeted disruption of sev-
eral genes in the prolactin pathway, including prolactin [6],
the prolactin receptor (PRLR) [7], Janus-2 kinase (Jak2) [8],
the transcription factor Stat5a [9] and both Stat5a and Stat5b
[10], leads to impaired mammary gland development and
lactation. In the case of the glucocorticoid receptor (GR),
abnormal ductal morphogenesis was observed when mam-
mary anlage from GR /  mice were transferred into
cleared fat pads of wild-type mice. However, mammary
gland development during pregnancy, lactation and involu-
tion was not perturbed, probably due to compensation for
GR loss by the mineralocorticoid receptor during these
stages of development [11].
Signaling pathways activated by prolactin and glucocor-
ticoids have been well characterised. Binding of prolactin to
its cognate receptor triggers dimerisation and leads to the
recruitment and activation of Jak2. Activated Jak2 then
phosphorylates the receptor and signal transducer and acti-
vator of transcription, Stat5 (both Stat5a and Stat5b iso-
forms). Phosphorylated Stat5a and Stat5b form homo- and
heterodimers and translocate to the nucleus where they bind
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activate specific genes [12,13]. The two Stat5 isoforms
share 96% homology and are coexpressed in the developing
mammary gland. Stat5 activation is highest in late pregnan-
cy and lactation, largely mediated by prolactin signaling,
although epidermal growth factor (EGF) and growth hor-
mone (GH) also contribute to Stat phosphorylation. In
addition to Jak–Stat activation, prolactin can also activate
other tyrosine kinases, including the Fyn, Src and Tec
kinases [14], as well as MAP kinase [15]. For glucocorticoid
signaling, binding of the ligand to its cognate glucocorticoid
receptor results in recruitment of the complex to glucocor-
ticoid response elements (GRE) that modulate the transcrip-
tion of target genes [16].
In mammary epithelial cells, optimal milk protein gene
expression requires both glucocorticoids and prolactin [17].
In the case of the h-casein promoter, the glucocorticoid
receptor is believed to act as a transcriptional coactivator for
Stat5 through physical association with Stat5 dimers [18],
thereby enhancing Stat5 activation. Cooperativity between
GR and Stat5 may also arise through GR binding to half-
palindomic GRE sites adjacent to GAS sites in the h-casein
promoter [19], although some experiments in vitro using
GR mutants defective in DNA binding or in genetically
modified mice do not support a requirement for DNA
binding by the GR to facilitate GR–Stat5 synergism [20].
A limited number of prolactin- or glucocorticoid-respon-
sive target genes in the mammary gland have been identi-
fied. For prolactin, the best-described targets are those
encoding milk proteins [1,2,21] and members of the Sup-
pressor of Cytokine Signaling (SOCS) family [22,23].
SOCS proteins provide a negative feedback signal to
attenuate prolactin signaling [22,24]. Although cyclin D1
[25,26], ERa [27] and pim-1 [28] were identified as Stat5
targets in other tissues, they are also likely to be relevant
targets in the mammary gland. Target genes of the gluco-
corticoid receptor in the mammary gland include sgk-1 [29]
and osteopontin [30]. Prolactin- and glucocorticoid-depen-
dent upregulation of BRCA1 expression has also been
reported [31].
To gain further insight into ‘early’ target genes activated
by a lactogenic stimulus, we applied representational differ-
ence analysis (RDA) to mouse mammary epithelial cells that
differentiate following prolactin and glucocorticoid treat-
ment. RDA is a sensitive method for identifying differen-
tially expressed genes between two populations. It utilises a
PCR-coupled amplification and subtractive process, where-
by enzymic digestion removes shared sequences and selec-
tion of novel cDNA sequences in the tester or driver sample
[32,33]. It can be more sensitive than other subtractive
cDNA methods, and has the potential of identifying small
differences in transcript levels. Here we report the identifi-
cation of Taxreb107 as a lactogenic-responsive gene. Our
results demonstrate that Taxreb107 is developmentally reg-
ulated in the mammary gland, and that inhibiting its func-
tion leads to reduced milk protein synthesis. Taxreb107 maytherefore play a role in the functional differentiation of
epithelium during mammary gland development.2. Materials and methods
2.1. Plasmids
The cDNA encoding full-length Taxreb107 was isolated
by RT-PCR from 12-day pregnant mouse mammary gland
mRNA and cloned into the pEF1a-rev-puro mammalian
expression vector that included an N-terminal Flag epitope.
Antisense Taxreb107 DNA, including 18 bp of 5Vuntrans-
lated sequence, was cloned into pEF1a-puro without an
epitope tag. Details are available on request.
2.2. Cell culture, differentiation assays and transfections
The majority of cell lines used here have been cited in
previous studies [34]. SCp2 mammary epithelial cells were
passaged in DMEM-F12 media containing DMEM-Ham’s
medium, 10% heat-inactivated fetal calf serum and insulin
5 Ag/ml. Differentiation was induced by the addition of
DMEM-F12 containing insulin (5 Ag/ml), hydrocortisone
(1 Ag/ml) and prolactin (5 Ag/ml) on extracellular matrix
(ECM) for 48 h, essentially as described [35]. The mouse
mammary epithelial cell line HC11 [36] was grown to
confluency in RPMI 1640 medium (Biofluids, Rockville,
MD) supplemented with 10% heat-inactivated fetal calf
serum, insulin (5 Ag/ml) and EGF (10 ng/ml). Prior to
lactogenic treatment, HC11 cells were maintained at con-
fluency for at least 24 h and then starved for 16 h in
medium lacking EGF (starvation medium). For studies of
prolactin-induced differentiation, EGF-starved HC11 cells
were incubated in starvation medium supplemented with
dexamethasone (1 AM) in the presence or absence of
prolactin (5 Ag/ml). Prolactin (human) was kindly provid-
ed by Dr A. Parlow (National Hormone and Pituitary
Program).
For stable transfection of HC11 cells, linearised antisense
Taxreb107 expression vector or empty vector (10 Ag) was
introduced into HC11 cells in 10-cm dishes using FuGENE
6 Transfection Reagent (Roche) and selected in puromycin
(2 Ag/ml) for 6–8 days. Pools of stable transfectants or
vector alone (control) were then used in the differentiation
assay. Flag-tagged Taxreb107 (1 Ag) was transiently
cotransfected with either antisense Taxreb107 or empty
vector (1 Ag) into kidney embryonal 293T cells, grown in
DME medium containing 10% fetal calf serum at 37 jC
with 5% CO2.
The antisense Taxreb107 oligodeoxynucleotide used in
the HC11 differentiation experiment was identical to that
previously reported by Li et al. [37] (5V-ACATAGCA-
GATCGGGAGT-3V). Confluent parental HC11 cells were
incubated in the absence or presence of antisense oligodeox-
ynucleotide (100 Ag/ml, Sigma Genosys), which was intro-
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subsequent treatment with prolactin.
2.3. Subtractive cDNA hybridisation by RDA
RDAwas carried out as previously described [38]. Brief-
ly, SCp2 cells in DMEM-F12 medium were plated on ECM
and treated with 5 Ag/ml insulin, 1 Ag/ml hydrocortisone and
either 5 Ag/ml prolactin, (‘tester’) or no prolactin (uninduced
‘driver’) for 48 h and total RNA isolated using RNAzol (Tel-
Test). Poly(A)+ RNAs were extracted from total RNAs using
the mRNA purification kit from Qiagen Inc. (Chatsworth,
CA) and 2–5 Ag of poly(A)+ RNA used to synthesize tester
cDNA (TimeSaver cDNA Synthesis Kit, Amersham Bio-
sciences, Inc.). Prior to the initial subtractive hybridisation,
DpnII-digested cDNA amplicons were electrophoresed on a
1% agarose gel, transferred to a Hybond N+ filter and probed
with h-actin for normalisation of the pools. Normalized
tester and driver amplicons were then hybridised to each
other at molar ratios of 1:100, 1:400 and 1:80,000 for each
successive round of RDA. After three rounds of hybrid-
isation and PCR, discrete DNA bands visualized on 1%
agarose gels were excised, isolated, and cloned into
pBluescriptR II KS+ (Stratagene). They were then sequenced
and compared to GenBankk and expressed sequence tag
(EST) databases using BLAST algorithms. To confirm
differential expression of the clones, cDNA from uninduced
and prolactin-induced SCp2 cells, normalised for h-actin
levels, was transferred to Hybond N+ filter strips and
hybridised with a radiolabeled fragment from each clone.Fig. 1. Lactogenic hormone-inducible genes identified by RDA in SCp2 cells.
amplicon, and amplicons generated following the first round of PCR amplification
gel on the right (DP3) were excised for sequencing. Molecular weight markers
radiolabeled fragments representing 11 genes identified in the RDA screen (refer to
or presence (+) of a lactogenic stimulus that included prolactin and dexamethason
integrity. (GenBankk accession numbers).2.4. Western blot analysis, Northern blotting and RT-PCR
Ten micrograms of lysate from 293T transfectants was
loaded per lane, subjected to electrophoresis and transfer, and
probed with monoclonal a-Flag antibody (Sigma Chemical
Co, St. Louis) and analysed using the ECL detection system
(Amersham). Northern blots of total RNAs (10 Ag), isolated
using RNAzol (Tel-Test), from HC11 cells and mouse mam-
mary glands at different stages of development as well as
poly(A)+ RNAs (3 Ag) from various breast cancer cells were
probed with radiolabeled mouse Taxreb107 and GAPDH
fragments. cDNA synthesis from total mRNA and RT-PCR
were performed using primers for h-casein and hypoxanthine
phosphoribosyltransferase (HPRT) as described [24]. Sam-
ples were fractionated on agarose gels, blotted and then
hybridised with specific internal radiolabeled oligonucleo-
tides. Relative levels were analysed using the public domain
NIH Image program (http://rsb.info.nih.gov/nih-image/).
2.5. Quantification of mRNA expression levels by real-time
PCR
Quantitative PCR was performed by real-time PCR using
the Rotor Gene 2000 (Corbett Research) with primers for h-
casein and HPRT. Sequences of the h-casein primers were:
forward 5V-ATGAAGGTCTTCATCCTCGCC-3V and re-
verse 5V-GATGTTTTGTGGGACGGGATTG-3V. Sequences
of the HPRT primers were: forward 5V-CACAGGACTA-
GAACACCTGC-3V and reverse 5V-GCTGGTGAAAAG-
GACCTCT-3V. Threshold values of standards were used to
sica Acta 1642 (2003) 139–147 141(A) Ethidium-bromide-stained agarose gels showing the original cDNA
and subtraction (DP1). The bands and intervening gel regions shown in the
are also shown. (B) cDNA prepared from SCp2 cell mRNA, probed with
the list in Table 1). The SCp2 cells were plated on ECM in the absence ()
e for 48 h. The h-actin probe was used as a control for cDNA loading and
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the samples were estimated.3. Results
3.1. RDA of SCp2 cells
The SCp2 mammary epithelial cell line was utilized to
identify genes activated following lactogenic stimulation
[35]. This cell line was originally isolated from the mammary
glands of a mid-gestation mouse, and undergoes differentia-
tion in the presence of ECM and a lactogenic stimulus
consisting of prolactin, insulin and glucocorticoid (hydrocor-
tisone). SCp2 cell differentiation results in the synthesis of
milk proteins includingh-casein, which are readily detectable
at the RNA level at 48 h and provide molecular markers of
differentiation. Nomilk gene transcripts are detectable by RT-
PCR of mRNA derived from cells plated on ECM in the
absence of a lactogenic stimulus (data not shown).
To identify lactogenic-responsive genes in SCp2 cells, we
employed the PCR-based strategy termed representational
difference analysis. TwoRNA populations were derived from
SCp2 cells plated on ECM in either the presence (‘tester
cDNA’) or absence (‘driver cDNA’) of the lactogenic stim-
ulus for 48 h. The cDNA was subjected to three successive
rounds of subtraction and amplification to identify transcripts
that were unique to the lactogenic hormone-induced popula-Table 1
cDNA amplicons identified by RDA
Gene name Accession
number
Comment on gene function
Taxreb107
(Rp L6)
X81987 Transcription factor. Also ribosomal protein
L6.
Rrg D10837 Ras recision gene, also known as lysyl
oxidase (Lox).
A prolactin target in uterus [40];
dexamethasone [43] and estrogen [54]
inducible.
Bag-1 AF022223 Bcl-2 binding protein; a prolactin target [39].
Bdm2
(Hfb2)
AF031483 Brain development gene.
Whsc2 AF101435 Wolf–Hirschhorn candidate gene 2.
Srm NM_009272 Spermidine synthase; induced by




XM_130171 Lipocalin-oncogene; secreted factor with
proapoptotic activity [55].
TRIP15 BC023096 Thyroid receptor interacting protein; also
known as signalosome component COPS2
or alien-like protein.
EST I AK004270 Weak similarity to neuroprotective protein.
EST II NM_026009
EST III BC026471 EST derived from TGFa mammary tumor
model; weak similarity to protein FLJ20489.
RDA was carried out to identify gene products whose expression was
upregulated following prolactin stimulation of SCp2 cells. Upregulation
was confirmed for the gene sequences listed (Fig. 1B).
Fig. 2. Taxreb107 mRNA is induced by prolactin and dexamethasone in
HC11 cells. (A) Northern blot analysis of total mRNA (10 Ag) from HC11
mouse epithelial cells treated with prolactin and dexamethasone for the
times shown (h). An increase in Taxreb107 transcripts was seen by 4 h. An
oligonucleotide specific for 18S ribosomal RNA provided a loading
control. (B) RT-PCR analysis of h-casein mRNA induction in HC11 cells
treated in the presence (+) or absence () of prolactin and dexamethasone
(dex) for the times indicated. Both stimuli were necessary for h-casein
induction. (C) RT-PCR analysis of the kinetics of h-casein mRNA
induction in HC11 cells following a lactogenic stimulus. HPRT was used
as a control for loading.tion. As shown in Fig. 1A, the complexity of the bands
decreased after three rounds of subtraction. Discrete bands
from the third round of RDAwere excised from agarose gels
and cloned. A total of 1312 clones were screened. Homolo-
gous clones were identified by hybridisation screening,
resulting in 63 distinct amplicons, which were then se-
quenced and identified by BLAST (NCBI) database searches.
Of these, 19 were selected for further analysis on the basis of
database searches. Three sequences, including ras-recision
gene (lysyl oxidase/lox), the Bcl-2 interacting gene, Bag-1,
and spermidine synthase corresponded to genes that have
previously been shown to be either prolactin and/or gluco-
coricoid responsive [39–42]. Milk protein genes a- and h-
casein were not identified as their cDNA sequences do not
contain two DpnII sites, thereby precluding their identifica-
tion by the RDA strategy. To determine whether any of the 19
cDNAs identified were upregulated at the RNA level, spe-
cific probes were hybridised against the original tester and
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reb107 and three Expressed Sequence Tags (ESTs), were
expressed at elevated levels following SCp2 induction (Fig.
1B). These sequences are summarised in Table 1. Expression
levels remained unchanged for the remaining eight amplicons
(data not shown).
TAXREB107 is a leucine zipper transcription factor that
interacts with the Human T-cell leukemia virus type 1
(HTLV-1) transactivator protein Tax. In association with
Tax, Taxreb107 directly binds the tax response element in
the viral promoter and mediates transcriptional activity.
Unlike TAXREB107, Tax does not bind DNA directly.
TAXREB107 has recently been identified as an erythropoi-
etin early response gene [37]. Intriguingly, the prolactin
receptor belongs to the same growth factor receptor family
as the erythropoietin receptor. Taxreb107 was selected for
further analysis on this basis and because of its proposed
function in other tissues as a transcriptional regulator of
differentiation.
3.2. Taxreb107 expression is rapidly induced in HC11 cells
and is developmentally regulated in the mouse mammary
gland
To verify the induction of Taxreb107 in a different
mammary epithelial cell line following a lactogenic stim-
ulus, we utilised HC11 cells (Fig. 2A). HC11 cells can beFig. 3. Taxreb107 is developmentally regulated in the mouse mammary gland. (A)
age), pregnant (12, 16 and 18 days pregnant, dp), lactating (1 and 8 days, dL) and
mRNA were hybridised with a radiolabeled fragment of mouse Taxreb107, rev
ribosomal probe served as a loading control. (B) Taxreb107 poly(A)+ RNA levels
HBL-100) or breast cancer cell lines. Glyceraldehyde-3-phosphate dehydrogenaseinduced by withdrawal of EGF and exposure to prolactin
and dexamethasone [36]. Unlike SCp2 cells, HC11 cells
do not require ECM to undergo in vitro differentiation.
However, like SCp2 cells, they are dependent on the
presence of both prolactin and glucocorticoid for milk
gene expression (Fig. 2B), which is evident by RT-PCR
at 24 h (Fig. 2B,C). Northern blot analysis of HC11 cells
revealed upregulation of Taxreb107 within 4 h following
the addition of prolactin and dexamethasone, with peak
levels occurring at approximately 12 h (Fig. 2A). Thus,
Taxreb107 expression was induced in two cellular systems
following a lactogenic stimulus, and its induction preceded
h-casein induction.
To examine whether Taxreb107 levels vary during mam-
mary gland development, Northern blot analysis was carried
out on mRNA derived from glands of virgin, pregnant,
lactating and involuting mice. Low levels were apparent in
the adult mammary gland, with a marked induction of
expression (four- to five-fold) observed in mid- to late
pregnancy (Fig. 3A). High levels were also noted in post-
parturition lactating glands, but rapidly diminished during
involution that accompanies forced weaning, returning to
similar levels as those seen in the virgin glands. The
expression profile of TAXREB107 in human breast cancer
cell lines and immortalised mammary epithelial cell lines
suggested that TAXREB107 is not deregulated during breast
tumorigenesis (Fig. 3B). Thus, Taxreb107 is developmen-Northern blot analysis of mammary glands from adult virgin (6–12 weeks
force-weaned (1 day involution, dI) mice. Filters containing 10 Ag of total
ealing a single transcript of 1.2 kb. An oligonucleotide specific for 18S
do not differ substantially between different human breast epithelial (184,
(GAPDH) served as a control.
Fig. 4. Antisense Taxreb107 decreases h-casein RNA levels in prolactin-
induced HC11 mammary epithelial cells. (A) Pools of cells stably expressing
a plasmid encoding antisense Taxreb107 or vector control sequences were
analysed for h-casein expression by RT-PCR, 24 h after induction with
prolactin and dexamethasone (+). Cells treated with dexamethasone alone
() served as a negative control. Two independent representative trans-
fections are shown. The number of PCR cycles used is shown for each lane.
HPRT was used as a marker for loading. (B) Determination of h-casein
mRNA levels by real-time PCR of cDNA.All valueswere adjusted relative to
that of control HPRT levels. The data shown represents the average of two
independent experiments performed in duplicate. Error bars = standard
deviation. (C) Validation of efficiency of Taxreb107 antisense construct by
Western blot analysis. 293T cells were transiently cotransfected with a
plasmid encoding FLAG-tagged Taxreb107 and either an antisense
Taxreb107 construct or empty vector control. Levels of Taxreb107 protein
were monitored in cell lysates by anti-FLAG immunoblotting. (D) Confluent
HC11 cells were cultured in the presence (+) or absence () of Taxreb107
antisense oligodeoxynucleotide, during EGF withdrawal and subsequent
prolactin and dexamethasone stimulation (I) or during the lactogenic stimulus
alone (II).h-caseinmRNA levels detected at 26 and 28 cycles by RT-PCR are
shown. HPRT mRNA, detected at 15 and 17 cycles.
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uniform levels in breast cancer cell lines.
3.3. Taxreb107 inhibition is associated with reduced
b-casein expression
Since Taxreb107 was induced following induction of
differentiation in HC11 and SCp2 cells, we assessed whether
inhibition of endogenous Taxreb107 levels was associated
with reduced differentiation, using h-casein expression as the
molecular marker. HC11 cells were stably transfected with
either an antisense Taxreb107 construct or empty vector, and
induced with prolactin and dexamethasone. Reduced levels
of h-casein mRNAwere observed at 24 h in the presence of
the antisense Taxreb107 expression vector, as determined by
semiquantitative PCR (Fig. 4A). h-casein expression was
very low after 26 and 28 cycles of PCR, whereas it was
readily detectable in vector control samples. There was no
apparent change in the level of HPRT, utilised as a measure of
cDNA loading and integrity. Reduced h-casein mRNA levels
were verified using quantitative real-time PCR (Fig. 4B),
where approximately four-fold less h-casein mRNAwas ob-
served in the presence of the antisense Taxreb107 construct.
Although there was no available antibody to assess endoge-
nous Taxreb107 levels, it is noteworthy that the antisense
construct was functional in 293T cells transfected with a Flag
epitope-tagged Taxreb107 expression vector, in which it
markedly inhibited the levels of FLAG-Taxreb107 (Fig.
4C). This inhibition was likely to be specific for Taxreb107,
since this antisense construct did not alter levels of p27 or
cyclin A, which have short half lives (data not shown).
The differentiative capacity of parental HC11 cells was
also assessed following the inhibition of Taxreb107 expres-
sion using antisense oligodeoxynucleotides. Confluent
HC11 cells were incubated with an antisense oligodeoxy-
nucleotide that was previously shown to inhibit Taxreb107
expression in erythroid cells [37]. The addition of antisense
Taxreb107 oligonucleotides to HC11 cells during EGF
withdrawal resulted in reduced h-casein expression follow-
ing the lactogenic stimulus, consistent with the findings
described above (Fig. 4D,I). In contrast, HPRT levels
remained unaltered. The attenuation in h-casein expression
by Taxreb107 was mediated through lactogenic hormone
treatment rather than EGF withdrawal, since the reduction in
h-casein was just as effective when antisense oligonucleo-
tide was added during the final differentiation step mediated
by prolactin and dexamethasone (Fig. 4D,II). Therefore,
perturbing the induction of Taxreb107 that normally accom-
panies HC11 mammary epithelial differentiation reduces
their differentiation capacity.4. Discussion
Prolactin plays a critical role in proliferation, differenti-
ation and secretory function of the mammary gland. Stat5a
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functional differentiation [9]. Using RDA, we have identi-
fied 11 genes upregulated by prolactin and dexamethasone
in mouse mammary epithelial cells. Here we report Tax-
reb107 as a novel lactogenic hormone-inducible gene in
these cells. Taxreb107 levels were found to be modulated
during mammary gland development and a regulatory role
during mammary epithelial differentiation was suggested by
the inhibition of milk protein gene synthesis that accom-
panies inhibition of Taxreb107. Of the remaining 10 genes,
two (Bag-1 and ras recision gene) have previously been
reported as prolactin target genes in other tissues. Bag-1,
which is a Bcl-2 binding protein that facilitates the anti-
apoptotic functions of Bcl-2, has been shown to be upregu-
lated in the prolactin responsive Nb2 lymphoma cell line
[39]. Bag-1 may contribute to prolactin-mediated cell sur-
vival. Ras recision gene (Rrg) is a prolactin target gene in
uterus, although in this tissue its expression is repressed by
prolactin [40]. Dexamethasone has also been shown to
induce Rrg [43]. Rrg could contribute to mammary epithe-
lial differentiation by reducing ras activity, since ras has
been shown to block lactogenic signaling in mammary
epithelial cells [44,45]. We also identified spermidine syn-
thetase, which has previously been shown to mediate the
lactogenic action of glucocorticoids [41].
Taxreb107 was initially identified as ribosomal protein
(Rp) L6 [46], one of over 80 proteins that are assembled in
the ribosome. However, there is emerging evidence that
ribosomal proteins can have important additional functions.
These include RpL5 in rRNA transport [47] and RpS4 as a
tumor suppressor [48]. Taxreb107 was also discovered as
one of several transcription factors that bound to the human
T-cell leukemia virus type I (HTLV-1) 5V long terminal
repeat (LTR) enhancer. This results in the transcriptional
activation of the viral Tax protein and oncogenic transfor-
mation to T-cell leukemia. Tax itself was found to interact
with TAXREB107, thereby providing an autocrine mecha-
nism for enhancing viral replication. In addition to activat-
ing its own viral promoter, Tax also activates target genes in
mammalian cells, including c-fos, vimentin, interleukin-2
and granulocyte-macrophage colony stimulating factor
(GM-CSF). Tax has also been shown to interact with other
transcription factors, including CREB and MyoD and there-
by activate promoters of cellular target genes.
The central portion of Taxreb107 contains a highly
conserved basic-Leucine Zipper (bZip) motif, necessary
for binding DNA and its transcriptional activity. The C-
terminus has been shown to interact with RNA on the basis
of structural and functional studies, consistent with it
originally being identified as a ribosomal protein. The N-
terminus, which is the most divergent region between
species, contains numerous basic residues and probably
mediates protein–protein interactions. Subcellular localisa-
tion studies indicate multiple functions since Taxreb107 is
both cytoplasmic and nuclear in location, with abundant
levels in nucleoli, consistent with a ribosomal function [49].Taxreb107 is developmentally regulated in the mammary
gland, with increased levels coinciding with differentiation
and Stat5 activation. Moreover, inhibition of Taxreb107
expression in our experiments blocked functional differen-
tiation in HC11 mammary epithelial cells. Taken together,
the data suggests that Taxreb107 plays a role in the
lactogenic hormone induction of differentiation. Notably,
similar findings have been reported during avian myogen-
esis, where Taxreb107 positively modulated myogenic reg-
ulatory factors, promoting skeletal muscle gene expression
[49]. Taxreb107 has also been shown to be upregulated in
neuronal NTERA2 cells upon differentiation [50] and dur-
ing hepatic regeneration [51], although its role in mediating
these events was not explored. In hemopoietic cells, Tax-
reb107 was induced following erythropoietin treatment of
Rauscher murine erythroleukemia cells [37]. Significantly,
both the Epo receptor and PRLR both belong to the same
family of cytokine receptors and utilise similar signaling
pathways. Contrary to these observations in a variety of
cellular differentiation systems, Taxreb107 mRNA was
reported to be down-regulated following TPA-induced
monocytic differentiation [52]. Thus, Taxreb107 appears
to be an early response gene induced during the functional
differentiation of select cell types, including mammary
epithelial cells.
Recent cloning of the mouse Taxreb107 promoter has
provided some clues into mechanisms that mediate its
activation. The promoter region induces high and constitu-
tive reporter activity [53], and contains motifs found in
many ribosomal proteins including a pyrimidine-rich start
region and nonmethylated CpG islands. Notably, the pro-
moter contains at least three Stat recognition sites that might
account for prolactin responsiveness. Our findings reported
here suggest that Taxreb107 is an ‘early’ response gene that
contributes to establishing a genetic programme important
for functional differentiation of the mammary gland. The
mechanism by which Taxreb107 influences differentiation
will require identification of targets of this transcriptional
coregulator in mammary epithelial cells.Acknowledgements
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